Adhesions Breast Health and Breast CareElectronic Health Records (EHRs)EndometriosisFibroidsGestational Diabetes Gynecologic OncologyInfertilityMalpracticeMenopause Osteoporosis
Polycystic Ovary SyndromePostpartum DepressionPelvic PainPremenstrual Syndrome/Premenstrual Dysphoric Disorder (PMS/PMDD)Pregnancy and BirthSex-related IssuesUrogynecologyUterine (Endometrial) PolypsWeight ManagementYoung Women
ContraceptionFetal MonitoringHysterectomy
FDA adds boxed warning to fezolinetant for rare serious liver injury
Published: December 17th 2024 | Updated: December 17th 2024The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.
Read More